Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination - Velentgas - 2012 - Pharmacoepidemiology and Drug Safety - Wiley Online Library
Par un écrivain mystérieux
Description
Incidence of Guillain-Barré syndrome (GBS) in China: A national population-based study - The Lancet Regional Health – Western Pacific
PDF) Guillain-Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data
COVID-19 Vaccines and Guillain-Barre Syndrome Connection
Frontiers Population-Based Incidence of Guillain-Barré Syndrome During Mass Immunization With Viral Vaccines: A Pooled Analysis
Guillain-Barré syndrome after vaccination against COVID-19 - The Lancet Neurology
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination
Real-world data on the incidence and risk of Guillain–Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination
PDF) Pediatric Clinical Drug Trials in Low-Income Countries: Key Ethical Issues
Investigating Guillain-Barre Syndrome and Vaccines: Is There a Link?
Frontiers Guillain-Barre syndrome following COVID-19 vaccines: A review of literature
depuis
par adulte (le prix varie selon la taille du groupe)
.JPEG)
